Accredited InvestorsEmployee ShareholdersInstitutionsPrivate Companies Who We Serve Trading and Investing Data Solutions Private Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Browse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunities​Forge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All Insights Private Market Reports Market Insights Buying and Selling Pre-IPO​ All Reports​Private Market UpdatesForge Investment OutlookStartup News and Trends​Private Market Data and Analytics​Tech IPO Calendar for 2024​Private Market Explained​Buying Pre-IPO Shares​Selling Pre-IPO SharesGlossaryVideosFAQsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
Solutions
Insights
About
Who We Serve
Solutions
Trading and Investing
Institutional Trading
Individual Investing
Data Solutions
Private Asset Custody
Self-Directed IRA
Insights
Private Market Reports
Market Insights
Buying and Selling Pre-IPO​
About
Log In
Sign Up
Secondary Marketplace / Trade Private Companies / Buy and Sell Vedanta Biosciences Stock

Vedanta Biosciences Stock

vedantabio.comHealthcare / BioTech & PharmaFounded: 2010Funding to Date: $211.6MM

Vedanta Biosciences, founded in 2017, is a clinical-stage company that has developed immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays that seek to enable physicians to access live bacteria drugs that are designed to treat autoimmune and inflammatory diseases easily. Vedanta Biosciences is headquartered in Cambridge, Massachusetts.

Buy or sell Vedanta Biosciences stockLearn more about Vedanta Biosciences IPO

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Vedanta Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Vedanta Biosciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Vedanta Biosciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Vedanta Biosciences investors also invested in these private companies

Bristol Myers Squibb
Bill & Melinda Gates Foundation
Rock Springs Capital
Johnson & Johnson Innovation
Magnetar Capital
Pfizer
Reimagined Ventures
Skyviews Life Science
SV Investment
Shumway Capital
PureTech Health
Fosun Health Capital

Team

Management Team

Bernat Olle Ph.D
Co-Founder, Chief Executive Officer & Board Member
Ruslan Medzhitov Ph.D
Chairman of Scientific Advisory Board & Scientific Co-Founder
Kevin Coveney
Senior Vice President, Finance
Dan Littman Ph.D
Scientific Co-Founder & Scientific Advisory Board Member
Bruce Roberts Ph.D
Chief Scientific Officer
Erik Spek Ph.D
Senior Vice President and Head, Legal Affairs & Intellectual Property
Lou Vaickus MD
Chief Medical Officer
Alexander Rudensky Ph.D
Scientific Co-Founder & Scientific Advisory Board Member
Daniel Couto
Chief Technical Officer
Kenya Honda Ph.D
Scientific Co-Founder & Scientific Advisory Board Member
Debra Winslow
Vice President, Program Management & Operations Planning
B. Brett Finlay Ph.D
Scientific Co-Founder & Scientific Advisory Board Member

Board Members

John LaMattina Ph.D
PureTech Health
Bharatt Chowrira Ph.D
PureTech Health
Bennett Shapiro MD
PureTech Health

Vedanta Biosciences stock FAQs

plusminus

Can you buy Vedanta Biosciences stock?

As Vedanta Biosciences is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Vedanta Biosciences, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Vedanta Biosciences stock?

To invest in a private company like Vedanta Biosciences through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Vedanta Biosciences stock?

Yes, you may be able to sell your Vedanta Biosciences stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Vedanta Biosciences stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Vedanta Biosciences stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Vedanta Biosciences a public company?

No, Vedanta Biosciences is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Vedanta Biosciences’ stock price?

Vedanta Biosciences is a privately held company and therefore does not have a public stock price. However, you may access Vedanta Biosciences’ private market stock price with Forge Data.
plusminus

What is Vedanta Biosciences’ stock ticker symbol?

Vedanta Biosciences does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Vedanta Biosciences in the BioTech & Pharma sector

Colossal Biosciences
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.01B
Altos Labs
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$6.33B
ADARx Pharmaceuticals
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$827.77MM
Cytonics
Sector
Healthcare / BioTech & Pharma
 
 
AI Therapeutics
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$110MM
Egenesis
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$333.77MM
Apnimed
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$366.58MM
Pendulum Therapeutics
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$308.05MM
Element Biosciences
Sector
Healthcare / BioTech & Pharma
Last Round Est. Valuation
$1.05B
PHARMACEUTICAL TECHNOLOGY 04/26/2023

Vedanta Biosciences raises funds to advance defined bacterial consortia therapies

Vedanta Biosciences has raised $106.5m in financing to advance a pipeline of defined bacterial consortia therapies. Co-led by new investors the AMR Action Fund and AXA IM Alts, the investment syndicate also included existing investors Reimagined Ventures, the Bill & Melinda Gates Foundation, Atlantic Neptune, Fiscus Ventures, PEAK6 and Skyviews Life Science.
Business Wire 05/13/2019

Vedanta Biosciences Closes Extended $45.5 Million Series C Financing

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consorti
Browse More Insights
Trending Companies

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.